Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +40.04%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.54%
#4 OriginTrail OriginTrail +19.65%
#5 ApeX ApeX +18.92%
#6 Non-Playable Coin Non-Playable Coin +18.42%
#7 UnifAI Network UnifAI Network +17.64%
#8 Pons Pons +16.75%
#9 龙虾 (Lobster) 龙虾 (Lobster) +16.75%
#10 Zora Zora +16.03%
Coin of the day
Smilek to the Bank Smilek to the Bank
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.

Genovate Biotechnology Co., Ltd.

4130
Clasificación en acciones #21465
Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the... Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the research, development, production, and commercialization of various products. These offerings primarily aim to prevent and treat illnesses resulting from viral and bacterial infections. The company's diverse portfolio extends to drugs, active pharmaceutical ingredients (APIs), intermediates, and specialized release agents, which are crucial for addressing a range of health issues including cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune conditions. Complementing its pharmaceutical offerings, Genovate also manufactures controlled-release Western medicine formulations and cosmetic items. Established in 1982, the company's operations are headquartered in Hsinchu City, Taiwan.
Precio por acción
$0.84903405
Última sincronización: 2026-07-27
Capitalización bursátil
$106.63M
Cambio (1 día)
0.00%
Cambio (1 año)
38.69%
País
TW
Comercio Genovate Biotechnology Co., Ltd. (4130)

Categoría

Healthcare
Ganancias de Genovate Biotechnology Co., Ltd. (4130)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Genovate Biotechnology Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Genovate Biotechnology Co., Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH